Replies to post #365914 on Amarin Corp Plc (AMRN)

[shadolane]

That might be a good possibility.

The statin owner could also bear some of the cost of testing the product.

We may assume that this could be a lengthy project.

In any event, looks like other markets will eventually offset what's now going on in the US. And who knows, maybe there will be some legal relief here as well.